Literature DB >> 15887857

Risk factors associated to kidney stones in primary hyperparathyroidism.

S Corbetta1, A Baccarelli, A Aroldi, L Vicentini, G B Fogazzi, C Eller-Vainicher, C Ponticelli, P Beck-Peccoz, A Spada.   

Abstract

Nephrolithiasis is the most important clinical manifestation of primary hyperparathyroidism (PHPT), although nowadays this disorder is often asymptomatic. Clinical or biochemical differences between PHPT patients with and without nephrolithiasis have not been clearly identified in most of the previous studies. The aim of the study was to investigate clinical and biochemical parameters in kidney stone former (SF) and non-stone former (NSF) patients with PHPT in order to identify potential risk factors. Serum and plasma samples from 55 consecutive patients (43 females, 12 males) with PHPT were collected after overnight fasting; 24-h urine collection and a fresh sample of urine for sediment analysis were obtained from all patients. Clinical data were recorded in all. Out of 55 patients, 22 had kidney stones, which were symptomatic in 73%. SFs showed circulating PTH, total and ionized calcium, 1,25 dihydroxyvitamin D3, urinary calcium excretion and 24-h urine oxalate levels significantly higher than NSFs. Hypercalciuria was often concomitant with massive quantities of calcium oxalate crystals in urine sediment. Hypercalciuria and relatively high oxaluria were associated with stone formation with an odds ratio (OR) of 4.0 and 7.0, respectively, which rose to 33.5 when they coexisted. Hypomagnesuria and hypocitraturia were common in at least one third of all PHPT patients, but they were not associated to an increased OR. As expected, they were positively correlated with urine calcium excretion, suggesting that calcium, magnesium and citrate are commonly regulated at renal level. In conclusion, hypercalciuria, higher oxalate excretion and severe PHPT are associated with kidney stones in PHPT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887857     DOI: 10.1007/bf03345354

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  31 in total

1.  Characterization and evaluation of asymptomatic primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg; E Shane; M Parisien; D W Dempster
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

Review 2.  Microscopic hematuria diagnosis and management.

Authors:  G B Fogazzi; C Ponticelli
Journal:  Nephron       Date:  1996       Impact factor: 2.847

3.  Nephrolithiasis and bone involvement in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; T P Jacobs; E S Siris; F Gartenberg; D Seldin; T L Clemens; J P Bilezikian
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

4.  A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism.

Authors:  C Y Pak; M J Nicar; R Peterson; J E Zerwekh; W Snyder
Journal:  J Clin Endocrinol Metab       Date:  1981-09       Impact factor: 5.958

5.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

6.  Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.

Authors:  J M Baumann; K Lauber; F X Lustenberger; M Wacker; E J Zingg
Journal:  Urol Res       Date:  1985

7.  Human stones.

Authors:  K Lonsdale
Journal:  Science       Date:  1968-03-15       Impact factor: 47.728

8.  Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone sisease before and after parathyroidectomy.

Authors:  Vibe G Frøkjaer; Charlotte L Mollerup
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

9.  The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.

Authors:  A E Broadus; R L Horst; R Lang; E T Littledike; H Rasmussen
Journal:  N Engl J Med       Date:  1980-02-21       Impact factor: 91.245

10.  Role of citric acid in primary hyperparathyroidism with renal lithiasis.

Authors:  M V Alvarez-Arroyo; M L Traba; A Rapado; C de la Piedra
Journal:  Urol Res       Date:  1992
View more
  11 in total

1.  Occult urolithiasis in asymptomatic primary hyperparathyroidism.

Authors:  Yu-Kwang Donovan Tay; Minghao Liu; Leonardo Bandeira; Mariana Bucovsky; James A Lee; Shonni J Silverberg; Marcella D Walker
Journal:  Endocr Res       Date:  2018-02-05       Impact factor: 1.720

2.  Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Authors:  F Saponaro; F Cetani; L Mazoni; M Apicella; M Di Giulio; F Carlucci; M Scalese; E Pardi; S Borsari; J P Bilezikian; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-12-23       Impact factor: 4.256

3.  Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Authors:  C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola
Journal:  J Endocrinol Invest       Date:  2015-03-28       Impact factor: 4.256

4.  High prevalence of simple kidney cysts in patients with primary hyperparathyroidism.

Authors:  S Corbetta; C Eller-Vainicher; L Vicentini; S Carnicelli; F Sardanelli; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2009-05-26       Impact factor: 4.256

5.  Renal manifestations of primary hyperparathyroidism.

Authors:  Anurag Ranjan Lila; Vijaya Sarathi; Varsha Jagtap; Tushar Bandgar; Padma S Menon; Nalini Samir Shah
Journal:  Indian J Endocrinol Metab       Date:  2012-03

Review 6.  Renal lithiasis and nutrition.

Authors:  Felix Grases; Antonia Costa-Bauza; Rafel M Prieto
Journal:  Nutr J       Date:  2006-09-06       Impact factor: 3.271

Review 7.  Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Authors:  A A Khan; D A Hanley; R Rizzoli; J Bollerslev; J E M Young; L Rejnmark; R Thakker; P D'Amour; T Paul; S Van Uum; M Zakaria Shrayyef; D Goltzman; S Kaiser; N E Cusano; R Bouillon; L Mosekilde; A W Kung; S D Rao; S K Bhadada; B L Clarke; J Liu; Q Duh; E Michael Lewiecki; F Bandeira; R Eastell; C Marcocci; S J Silverberg; R Udelsman; K Shawn Davison; J T Potts; M L Brandi; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-09-09       Impact factor: 4.507

8.  Clinical Presentation of Primary Hyperparathyroidism in Older Adults.

Authors:  Elena Castellano; Roberto Attanasio; Alberto Boriano; Giorgio Borretta
Journal:  J Endocr Soc       Date:  2019-10-02

Review 9.  Advances in the diagnosis and the management of primary hyperparathyroidism.

Authors:  Ana Kashfia Islam
Journal:  Ther Adv Chronic Dis       Date:  2021-06-11       Impact factor: 5.091

10.  Biochemical characterization of primary hyperparathyroidism with and without kidney stones.

Authors:  Clarita V Odvina; Khashayar Sakhaee; Howard J Heller; Roy D Peterson; John R Poindexter; Paulette K Padalino; Charles Y C Pak
Journal:  Urol Res       Date:  2007-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.